The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Share News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,759.00
Bid: 1,758.00
Ask: 1,760.00
Change: -7.00 (-0.40%)
Spread: 2.00 (0.114%)
Open: 1,771.00
High: 1,771.00
Low: 1,755.00
Prev. Close: 1,766.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 25th Jan 2013 07:03

Aberdeen Asset Management: Goldman Sachs upgrades to buy with its target price at 360p.APR Energy: JP Morgan lowers target price from 1005p to 950p, while its overweight rating is left unchanged.Brooks Macdonald Group: Numis ups target price from 1400p to 1470p and retains a hold recommendation.Burberry: HSBC increases target price from 1300p to 1500p maintaining a neutral rating.Carphone Warehouse Group: Citigroup raises target price from 225p to 260p still recommending to buy.Chemring Group: UBS takes target price from 360p to 380p and retains a buy recommendation. JP Morgan ups target price from 255p to 300p staying with its overweight rating. Espirito Santo increases target price from 320p to 360p, while its buy recommendation is maintained.Croda International: Morgan Stanley moves target price from 2430p to 2700p and reiterates an overweight rating.C&W Communications: HSBC lowers target price from 56p to 41p downgrading from overweight to neutral.Debenhams: Seymour Pierce cuts target price from 100p to 95p and keeps a reduce rating.Dignity: N+1 Singer ups target price from 1096p to 1287p still recommending to buy.Dragon Oil: Citigroup reduces target price from 880p to 818p and maintains a buy recommendation.easyJet: Deutsche Bank raises target price from 940p to 1040p keeping its buy recommendation. Morgan Stanley moves target price from 1000p to 1060p and reiterates an overweight rating. UBS revises target price from 890p to 1000p and upgrades to buy. HSBC ups target price from 1000p to 1100p, while its overweight rating is unaltered. Citigroup takes price target from 930p to 980p and maintains a neutral rating.Enterprise Inns: Panmure Gordon raises target price from 87p to 123p and reiterates a buy recommendation.First Group: JP Morgan cuts target price from 245p to 237p and stays with an overweight rating.International Consolidated Airlines Group: JP Morgan upgrades to overweight.Johnson Matthey: Morgan Stanley increases target price from 2070p to 2298p keeping an underweight rating.Kingfisher: Goldman Sachs lowers target price from 360p to 340p and leaves its buy recommendation unchanged.Ladbrokes: Morgan Stanley shifts target price from 160p to 170p retaining an underweight rating.London Mining: JP Morgan moves target price from 200p to 215p and keeps an overweight rating. Citigroup ups target price from 180p to 200p still recommending to buy.London Stock Exchange Group: JP Morgan raises target price from 886p to 1050p, while reiterating an underweight rating. Numis downgrades to hold with a target price of 1128p.Man Group: Goldman Sachs downgrades to neutral.National Grid: Goldman Sachs shifts target price from 605p zo 609p and still recommends to sell.Ocado Group: Exane BNP increases target price from 90p to 140p and maintains an outperform rating.Petropavlovsk: Goldman Sachs downgrades to sell with a target price of 365p.Polymetal International: UBS takes price target from 1170p to 1300p upgrading to buy.St James's Place: Deutsche Bank ups target price from 465p to 485p, while its hold rating remains unchanged. JP Morgan revises target price from 457p to 496p and maintains an overweight rating. Numis increases target price from415p to 515p and upgrades to add.Synthomer: Morgan Stanley revises target price from 245p to 270p, while its overweight rating is reiterated.Thomas Cook Group: UBS raises target price from 24p to 75p and upgrades to buy. Citigroup downgrades to sell with a target price of 40p.TUI Travel: Citigroup takes target price from 175p to 300p, while leaving its neutral rating unaltered; Barclays reinstates at outperform and its target at 320p.United Drug: Investec initiates with a target price of 240p and a sell recommendation.United Utilities: HSBC moves target price from 720p to 770p keeping a neutral rating.Vesuvius: JP Morgan initiates with a target price of 420p and an overweight rating.
More News
19 Apr 2024 09:26

LONDON BROKER RATINGS: Peel Hunt starts NatWest and Barclays at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
10 Apr 2024 08:41

Johnson Matthey and BP win deal for US sustainable aviation fuel plant

(Alliance News) - Johnson Matthey PLC and BP PLC on Wednesday said their technology offering has been selected for use in a sustainable aviation fuel plant being built in the US state of Louisiana.

Read more
10 Apr 2024 07:47

LONDON BRIEFING: Stocks called up ahead of US inflation data

(Alliance News) - Stocks in London are called to open higher, as investors shake off nerves ahead of a key US inflation reading.

Read more
9 Apr 2024 09:51

Berenberg hikes target price on Johnson Matthey

(Sharecast News) - Analysts at Berenberg raised their target price on diversified chemicals business Johnson Matthey from 1,650.0p to 1,800.0p on Tuesday but said the performance of its shares will likely depend on three factors.

Read more
9 Apr 2024 08:54

LONDON BROKER RATINGS: Barclays raises Halma to 'overweight'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
9 Apr 2024 07:39

LONDON BRIEFING: HSBC sells Argentinian arm for USD550 million

(Alliance News) - Stocks in London are called to open lower on Tuesday, as investors nervously look ahead to US inflation data and the European Central Bank's latest interest rate decision.

Read more
25 Mar 2024 10:19

LONDON BROKER RATINGS: SocGen raises Sage; Numis cuts Virgin Money

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
20 Mar 2024 16:54

LONDON MARKET CLOSE: FTSE 100 treads water while Kering weighs on CAC

(Alliance News) - London's FTSE 100 finished the day largely as it started it, enduring an uninspiring session on Wednesday, with the latest Federal Reserve decision about an hour away.

Read more
20 Mar 2024 16:53

London close: Stocks mixed ahead of Fed, BoE decisions

(Sharecast News) - London markets closed with a mixed but little-changed performance on Wednesday, as investors digested a larger-than-expected slowdown in UK inflation.

Read more
20 Mar 2024 11:49

LONDON MARKET MIDDAY: Pre-Fed rate nerves push FTSE 100 in red

(Alliance News) - The FTSE 100 was in the red on Wednesday at midday, as relief from cooling UK inflation was not enough to shake off nerves ahead of the latest US Federal Reserve interest rate decision.

Read more
20 Mar 2024 08:45

LONDON MARKET OPEN: UK inflation cooler than expected ahead of BoE

(Alliance News) - The FTSE 100 in London opened lower on Wednesday morning, with cooler-than-expected inflation doing little to shake off pre-US Federal rate nerves.

Read more
20 Mar 2024 08:32

Johnson Matthey sells medical device components arm for USD700 million

(Alliance News) - Johnson Matthey PLC on Wednesday said it has agreed to sell its Medical Device Components business to Montagu Private Equity LLP, with the proceeds to fund a share buyback.

Read more
20 Mar 2024 07:40

LONDON BRIEFING: UK inflation cools to 3.4% in February; Eyes on Fed

(Alliance News) - Stocks in London are expected to open slightly lower on Wednesday, as investors digest some cooler-than-expected inflation in the UK and look ahead to the latest US interest rate decision.

Read more
20 Mar 2024 07:08

Johnson Matthey sells medical parts unit for $700m

(Sharecast News) - Johnson Matthey is selling its medical device components business to Montagu Private Equity for $700m (£550m), the company said on Wednesday.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.